November 3, 2022
João Dürr reviewed the past year and described the CDCB vision in the CEO Column from the 2022 Activity Report.
October 13, 2022
Jay Weiker, Chair of the CDCB Board of Directors, shares the CDCB progress and priorities of the past year in the newly-published 2022 Activity Report.
A monthly newsletter, details genetic evaluation updates and industry news.